top of page
PARK CITY 2025: RETINA - TKI AND DRUG DELIVERY SHOWCASE
Moderators: Robert L. Avery, MD, Program Co-Chair; Mark S. Humayun, MD, PhD, Professor of Ophthalmology, University of Southern California; Lejla Vajzovic, MD, Professor of Ophthalmology, Duke University School of Medicine
Room: Jordanelle Ballroom A
Start | Company | Presenter |
|---|---|---|
1:30 PM | Introduction | Robert L. Avery, MD, Program Co-Chair |
1:31 PM | EyePoint, Inc | Ramiro Ribeiro, MD, PhD, Chief Medical Officer |
1:36 PM | Discussion | |
1:38 PM | Ocular Therapeutix | Sanjay Nayak, MBBS, PhD, Chief Strategy Officer |
1:43 PM | Discussion | |
1:45 PM | Re-Vana Therapeutics | Michael O'Rourke, CEO |
1:50 PM | Discussion | |
1:52 PM | Valitor | Wesley M. Jackson, PhD, President & CSO |
1:57 PM | Discussion | |
1:59 PM | Optigo Biotherapeutics Inc. | Houman Hemmati, MD. PhD, Co-Founder & CMO |
2:04 PM | Discussion | |
2:06 PM | Ripple Therapeutics Corporation | Tom Reeves, Co-Founder & CEO, Ripple Therapeutics Corporation |
2:11 PM | Discussion | |
2:13 PM | EyeDura Therapeutics | Srini Venkatesh, PhD, CEO |
2:18 PM | Discussion | |
2:20 PM | Novaliq Inc | Christian Roesky PhD, CEO & President |
2:25 PM | Discussion | |
2:27 PM | Oculis | Sharon Klier, MD, MS, MPH, Chief Development Officer |
2:32 PM | Discussion | |
2:34 PM | GelMEDIX | Max Cotler, PhD, COO & President |
2:39 PM | Discussion | |
2:41 PM | Conclusion | Robert L. Avery, MD, Program Co-Chair |
Anchor 1
bottom of page